VOLT-AF IDE Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 392 participants.
Also called NCT06223789
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 392 participants
- Sponsor
- Registry
-
NCT06223789
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Austria, Belgium, Canada, Czechia, France, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT06223789. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-03 (actual); primary completion 2025-10-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VOLT-AF IDE Clinical Study
- Condition
- Atrial Arrhythmia
- Condition
- Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06223789- Content hash
9ffe00c0a50ef0456fa21bde8200666bb617ab0dc2343dbeb12dde4d369cef3a